Is the Wegovy pill really $149 a month, and how do I get that price?

Which Wegovy pill doses actually cost $149 a month?

The 1.5 mg and 4 mg tablet strengths cost $149 per month for cash-paying patients, per Novo Nordisk's published price guide. The 4 mg price is a limited-time offer running through August 31, 2026; after that date, 4 mg rises to $199 per month, while no end date has been announced for the 1.5 mg tier. The two higher strengths, 9 mg and 25 mg, are priced at $299 per month. One month is defined as one bottle of 30 tablets. These are self-pay prices through Novo Nordisk's own savings channels, not typical retail list prices, which can run higher without the offer.

How do I actually get the $149 price?

Two routes reach the same price, and both start with a prescription. The first is NovoCare Pharmacy, Novo Nordisk's direct home-delivery service: a licensed clinician sends the prescription there, and the medication ships to your door at the self-pay price. The second is TrumpRx, the government's direct-to-consumer drug pricing site, which links to a savings coupon you present at a participating local pharmacy along with a valid prescription. Either way, the prescription comes first, from your own physician or a telehealth provider. Availability varies by state. Telehealth prescribing rules, pharmacy options, and specific medications differ depending on where you live.

Who is excluded from the $149 offer?

Anyone using government healthcare coverage is excluded. Patients enrolled in Medicare, Medicaid, TRICARE, VA, or DOD health programs cannot use the cash offer, per the published terms. The price is also strictly self-pay: it cannot be submitted to commercial insurance or counted toward a deductible, and patients must be 18 or older and US residents. Novo Nordisk also states it "reserves the right to modify or cancel this program at any time," so the $149 figure is a manufacturer program, not a permanent list price.

What happens to the cost when the dose goes up?

The monthly price roughly doubles at maintenance doses. The FDA-approved label escalates oral Wegovy from 1.5 mg once daily through intermediate strengths toward a maintenance dose, and the 9 mg and 25 mg tablets are priced at $299 per month, not $149. That makes $149 best understood as the entry price. Anyone budgeting for a year of treatment should plan around the maintenance-dose price their physician ultimately settles on, plus the August 31, 2026 expiration of the 4 mg offer. Per the label, the tablet is taken on an empty stomach with a small amount of water at least 30 minutes before food.

Is the $149 starter dose the one that produced the weight loss results?

No. The published efficacy data come from the 25 mg maintenance dose, which sits in the $299 tier. In the OASIS 4 trial (New England Journal of Medicine, 2025), adults with overweight or obesity taking oral semaglutide 25 mg once daily lost an average of 13.6% of body weight over 64 weeks, versus 2.2% with placebo, alongside diet and exercise; among participants who stayed on treatment, the averages were 16.6% and 2.7%. Individual results vary. The 1.5 mg and 4 mg tablets are escalation steps rather than the studied maintenance dose, so the realistic long-term monthly cost for the regimen studied in the trial is $299, not $149.

What does the $149 include, and what will I still pay for?

The $149 covers the medication only: one 30-tablet bottle shipped by NovoCare Pharmacy or filled at a local pharmacy with the TrumpRx coupon. It does not include the clinician visit needed to get and maintain the prescription, any lab work a physician orders, or follow-up care, and those costs vary widely between telehealth platforms and in-person practices. For comparison, Sipra's membership is $99/mo and covers unlimited physician visits across categories, with medication priced separately and fixed by plan length; full cost is disclosed before checkout. The provider cost calculator can help you line up total monthly costs across providers before committing.

More questions, answered

Related questions